Although high titres of RF and ACPA are biomarkers associated with an increased risk of developing RA-ILD [46, 47], there was no relationship between RF positive status and mortality in RA-ILD patients in this meta-analysis. This evidence concerns the gene PRTN3 and rheumatoid arthritis.